# New Insights Into Advanced Glycation End Products Induced Melanogenesis and Intervention Strategies

**Authors:** Xi Yang, Mengqi You, Huanjun Zhou, Zhen Li, Guangwen He, Thomas Mammone, Nadine Pernodet, Jian Cao

PMC · DOI: 10.1111/jocd.70521 · Journal of Cosmetic Dermatology · 2025-10-21

## TL;DR

This study explores how advanced glycation end products (AGEs) cause skin darkening and finds potential treatments to block this process.

## Contribution

The study identifies AGEs as a novel contributor to melanogenesis and proposes a multi-target intervention strategy using DP, niacinamide, and green tea extract.

## Key findings

- AGEs increase melanin production and tyrosinase activity in skin cells and 3D skin models.
- DP breaks AGEs crosslinks and inhibits AGEs-induced melanogenesis.
- Niacinamide and green tea extract reduce IL-18/IL-33 secretion caused by AGEs.

## Abstract

Skin hyperpigmentation refers to areas of skin that become darker than the surrounding skin due to an increase in melanin production, which greatly impacts skin esthetics. UV exposure, intrinsic hormonal changes, or injury are the general causes of hyperpigmentation. Recently, studies indicated that advanced glycation end products (AGEs) contribute to hyperpigmentation. However, detailed mechanisms involved in this process as well as therapeutic solutions are yet to be explored.

This study aimed to investigate the underlying mechanisms as well as intervention strategies targeting AGEs‐induced melanogenesis.

The study exposed skin cells and 3D epidermal models to AGEs and measured melanin production and tyrosinase activity. Dimethoxytolyl propylresorcinol (DP), niacinamide, and green tea extract were tested for their ability to inhibit AGEs‐induced melanogenesis or related cytokines. The AGEs breaking efficacy of DP was assessed on glycated lysozyme by mass spectrometry, as well as on glycated skin cells and 3D full‐thickness skin models.

Exposure to AGEs stimulates tyrosinase activity and melanin production in melanocytes and 3D melanocyte‐containing epidermal skin models. AGEs upregulate IL‐33 expression in fibroblasts via NLRP1/Caspase1 activation. DP was discovered to be an effective AGEs crosslink breaker and also capable of inhibiting AGEs induced melanin production in skin models. Moreover, niacinamide and green tea extract effectively inhibit IL‐18/IL‐33 secretion stimulated by AGEs. Those 3 components work collectively to target different stages of AGEs induced melanogenesis in skin and appear to be a potent intervention strategy to treat skin hyperpigmentation and sallowness issues during the aging process.

## Linked entities

- **Proteins:** LOC103429692 (polyphenol oxidase, chloroplastic-like), IL33 (interleukin 33), NLRP1 (NLR family pyrin domain containing 1), Caspase1 (caspase-1), IL18 (interleukin 18)
- **Chemicals:** dimethoxytolyl propylresorcinol (PubChem CID 11594628), niacinamide (PubChem CID 936)

## Full-text entities

- **Genes:** IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, TYR (tyrosinase) [NCBI Gene 7299] {aka ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, NLRP1 (NLR family pyrin domain containing 1) [NCBI Gene 22861] {aka AIADK, CARD7, CIDED, CLR17.1, DEFCAP, DEFCAP-L/S}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}
- **Diseases:** Skin hyperpigmentation (MESH:D017495)
- **Chemicals:** niacinamide (MESH:D009536), green tea extract (MESH:C045651), melanin (MESH:D008543), DP (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12539759/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12539759/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12539759/full.md

---
Source: https://tomesphere.com/paper/PMC12539759